NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
12/31/2024
Back to search
Official data from USPTO
NECTX NEW ENGLAND CELL THERAPEUTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
68
Latest update
12/31/2024
Trademark type
Combined
Nice classes
5, 10, 40, 44
Filing date
01/31/2020
Registration date
12/31/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/31/2024
Last transaction
12/31/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
3
Owner type
03
Owner location
Osaka, JP
Examiner
CIANCI, RYAN MICHAEL
Law office
M70
Current location
INTENT TO USE SECTION
Mark description
The mark consists of a circular geometric design comprised of four elliptical shapes extending along the circumference of the circular design and one triangular shape, which in color form a light blue/seafoam green gradient. To the right of the design is the stylized word "NECTX" in blue located above the words "NEW ENGLAND CELL THERAPEUTICS" in light gray.
Holders and representatives
Holders
N. C. (pessoa física)
Representatives
Jerald E. Nagae, Reg. No. 29,418 Christensen O'Connor Johnson Kindness
Technical classification
Nice Classes
Class 5Class 10Class 40Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Cell preparationshuman cells for medical purposes for the treatment of diseases and disorders; Pharmaceutical preparations for the treatment of neurologicalbone and cerebral diseases and disorders
Class 10
Medical instruments and apparatus for treating neurologicalbonecerebral diseases and disorders with cell preparations; Cell culturing instruments and apparatus for medical usecell culturing container for therapeutic purposes
Class 40
Custom processing of human cells; Processing of therapeutic cells
Class 44
Medical treatment services with cell preparations; Medical treatment services with cultivated cells; Providing medical information; Cultivation of cells taken from patients for medical transplant; Custom cultivation of cells for medical purposes
Publications
History of USPTO decisions and trademark events.
68 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
12/31/2024
DP1B
1(B) BASIS DELETED; PROCEED TO REGISTRATION
12/10/2024
IUCN
NOTICE OF ALLOWANCE CANCELLED
11/01/2024
D1BR
TEAS DELETE 1(B) BASIS RECEIVED
11/01/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
03/09/2024
EX5G
SOU EXTENSION 5 GRANTED
03/08/2024
EXT5
SOU EXTENSION 5 FILED
03/08/2024
EEXT
SOU TEAS EXTENSION RECEIVED
03/08/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/05/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/05/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/05/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
12/05/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
12/05/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
08/24/2023
EX4G
SOU EXTENSION 4 GRANTED
08/22/2023
EXT4
SOU EXTENSION 4 FILED
08/22/2023
EEXT
SOU TEAS EXTENSION RECEIVED
08/22/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
02/24/2023
EX3G
SOU EXTENSION 3 GRANTED
02/22/2023
EXT3
SOU EXTENSION 3 FILED
02/22/2023
EEXT
SOU TEAS EXTENSION RECEIVED
02/22/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
09/22/2022
EX2G
SOU EXTENSION 2 GRANTED
09/20/2022
EXT2
SOU EXTENSION 2 FILED
09/20/2022
EEXT
SOU TEAS EXTENSION RECEIVED
09/20/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
01/28/2022
EX1G
SOU EXTENSION 1 GRANTED
01/26/2022
EXT1
SOU EXTENSION 1 FILED
01/26/2022
EEXT
SOU TEAS EXTENSION RECEIVED
01/26/2022
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
11/16/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/21/2021
PUBO
PUBLISHED FOR OPPOSITION
09/21/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/01/2021
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
08/18/2021
ALIE
ASSIGNED TO LIE
08/18/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/17/2021
XAEC
EXAMINER'S AMENDMENT ENTERED
08/17/2021
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
08/17/2021
GNEA
EXAMINERS AMENDMENT E-MAILED
08/17/2021
CNEA
EXAMINERS AMENDMENT -WRITTEN
08/17/2021
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
08/17/2021
PBSR
WITHDRAWN FROM PUB - SENIOR ATTORNEY REQUEST
08/17/2021
CNEA
EXAMINERS AMENDMENT MAILED
08/16/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/02/2021
XAEC
EXAMINER'S AMENDMENT ENTERED
08/02/2021
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
08/02/2021
GNEA
EXAMINERS AMENDMENT E-MAILED
08/02/2021
CNEA
EXAMINERS AMENDMENT -WRITTEN
08/02/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/30/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/30/2021
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
04/01/2021
GNSI
INQUIRY TO SUSPENSION E-MAILED
04/01/2021
CNSI
SUSPENSION INQUIRY WRITTEN
04/01/2021
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
03/02/2021
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
10/01/2020
GNSL
LETTER OF SUSPENSION E-MAILED
10/01/2020
CNSL
SUSPENSION LETTER WRITTEN
10/01/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/14/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/14/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/14/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/17/2020
GNRT
NON-FINAL ACTION E-MAILED
03/17/2020
CNRT
NON-FINAL ACTION WRITTEN
03/17/2020
DOCK
ASSIGNED TO EXAMINER
03/13/2020
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
02/06/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/05/2020
NWAP
NEW APPLICATION ENTERED
02/04/2020
Continuous trademark protection
Get notified about every new filing that threatens NECTX NEW ENGLAND CELL THERAPEUTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.